These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 12448442)

  • 1. States combat drug costs.
    Consum Rep; 2002 Dec; 67(12):8-9. PubMed ID: 12448442
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmaceuticals issue brief: pharmaceutical assistance programs: year end report--2004.
    Seay M
    Issue Brief Health Policy Track Serv; 2004 Dec; ():1-26. PubMed ID: 15724309
    [No Abstract]   [Full Text] [Related]  

  • 3. Rx for Medicaid: with Medicaid costs rising and revenues declining, states are looking at what to do.
    Tobler L; Folkemer D
    State Legis; 2003 Apr; 29(4):16-20. PubMed ID: 12678012
    [No Abstract]   [Full Text] [Related]  

  • 4. Forecasting the future.
    Tecnologica; 1999 Dec; ():1, 3-6, 14-5. PubMed ID: 10848110
    [No Abstract]   [Full Text] [Related]  

  • 5. Trends in prescription drug expenditures by Medicaid enrollees.
    Banthin JS; Miller GE
    Med Care; 2006 May; 44(5 Suppl):I27-35. PubMed ID: 16625061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic conditions and disabilities: trends and issues for private drug plans.
    Boccuti C; Moon M; Dowling K
    Policy Brief Commonw Fund; 2003 Oct; (680):1-10. PubMed ID: 14562797
    [No Abstract]   [Full Text] [Related]  

  • 7. Medicaid prescription drug coverage: state efforts to control costs.
    Gencarelli DM
    NHPF Issue Brief; 2003 May; (790):1-17. PubMed ID: 12751504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. State Medicaid prescription drug expenditures for Medicare-Medicaid dual eligibles: estimates of Medicaid savings and federal expenditures resulting from expanded Medicare prescription coverage.
    Dale SB; Verdier JM
    Issue Brief (Commonw Fund); 2003 Apr; (627):1-12. PubMed ID: 12685428
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug-altered states. As pharmaceutical spending continues to soar, state legislatures are taking bold steps to rein in their costs.
    Tieman J
    Mod Healthc; 2002 Apr; 32(17):28-31. PubMed ID: 12024771
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug coverage for Medicare beneficiaries: why protection may be in jeopardy.
    Briesacher B; Stuart B; Shea D
    Issue Brief (Commonw Fund); 2002 Jan; (505):1-8. PubMed ID: 11922051
    [No Abstract]   [Full Text] [Related]  

  • 11. Plans confront specialty pharmacy's escalating costs in variety of ways.
    Reinke T
    Manag Care; 2010 Dec; 19(12):12-3, 15-6, 19. PubMed ID: 21291126
    [No Abstract]   [Full Text] [Related]  

  • 12. These doctor's mission: keeping drug costs down.
    Guglielmo WJ
    Med Econ; 2001 Apr; 78(8):108-10, 113-6. PubMed ID: 11386066
    [No Abstract]   [Full Text] [Related]  

  • 13. Managing Medicaid drug expenditures.
    Sudovar SG; Rein SD
    J Health Hum Resour Adm; 1978 Nov; 1(2):200-30. PubMed ID: 10308767
    [No Abstract]   [Full Text] [Related]  

  • 14. Medicaid reimbursement. Issue brief.
    Berry MD
    Issue Brief Health Policy Track Serv; 2009 Jan; ():1-13. PubMed ID: 19297676
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmaceuticals: pharmaceutical cost control measures: year end report-2002.
    Kammer C
    Issue Brief Health Policy Track Serv; 2002 Dec; ():1-14. PubMed ID: 12856689
    [No Abstract]   [Full Text] [Related]  

  • 16. US spending on prescription drugs rose by 19% in 2000.
    Charatan F
    BMJ; 2001 May; 322(7296):1198. PubMed ID: 11358763
    [No Abstract]   [Full Text] [Related]  

  • 17. Prescription drug benefits: promising solutions.
    Goff VV
    Issue Brief (Inst Health Care Costs Solut); 2002; 1(4):1-16. PubMed ID: 12825600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drugs: budget busters or cost cutters in future health care?
    Egger E
    Health Care Strateg Manage; 1999 Mar; 17(3):1, 22-3. PubMed ID: 10351640
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of the state as a drug purchaser.
    Palumbo FB
    Food Drug Law J; 2001; 56(3):267-80. PubMed ID: 11944639
    [No Abstract]   [Full Text] [Related]  

  • 20. Controlling pharmacy costs in the NC Medicaid program.
    Dobson LA
    N C Med J; 2003; 64(6):280-2. PubMed ID: 14983617
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 19.